FAT1 and neoplasm: The mutation survival analysis of the top four tumors with more than 15% mutation rate demonstrated that FAT1 mutations in UCEC predicted better prognosis for tumor patients, but FAT1 mutations in HNSC predicted poor survival (Fig. 4D).